167 related articles for article (PubMed ID: 19169521)
1. Effect of topical 0.5% povidone-iodine compared to 5% natamycin in fungal keratitis caused by Fusarium solani in a rabbit model: a pilot study.
Oliveira LA; Takata TT; Shiguematsu AI; Melo Júnior LA; Gompertz OF; Sousa LB; Mannis MJ
Arq Bras Oftalmol; 2008; 71(6):860-4. PubMed ID: 19169521
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
Edwar L; Janna YM; Rozaliyani A; Louisa M
Mycoses; 2020 Oct; 63(10):1128-1132. PubMed ID: 32780874
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of intrastromal injection of 5% natamycin in experimental fusarium keratitis.
Mimouni M; Tam G; Paitan Y; Kidron D; Segev F
J Ocul Pharmacol Ther; 2014 Sep; 30(7):543-7. PubMed ID: 24919100
[TBL] [Abstract][Full Text] [Related]
4. Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis.
Panda A; Ahuja R; Biswas NR; Satpathy G; Khokhar S
Cornea; 2003 Mar; 22(2):138-41. PubMed ID: 12605049
[TBL] [Abstract][Full Text] [Related]
5. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis.
Melki SA; Safar A; Yaghouti F; Scharper P; Scharper M; Zeligs B; MacDowell AL; Goldberg MA; Lustbader J
Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):459-62. PubMed ID: 10901479
[TBL] [Abstract][Full Text] [Related]
6. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis.
Kalavathy CM; Parmar P; Kaliamurthy J; Philip VR; Ramalingam MD; Jesudasan CA; Thomas PA
Cornea; 2005 May; 24(4):449-52. PubMed ID: 15829804
[TBL] [Abstract][Full Text] [Related]
7. Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.
Yavas GF; Oztürk F; Küsbeci T; Cetinkaya Z; Ermis SS; Kiraz N; Inan UU
Graefes Arch Clin Exp Ophthalmol; 2008 Feb; 246(2):275-9. PubMed ID: 17912543
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and oxidative stress in corneal tissue in experimental keratitis due to Fusarium solani: Amelioration following topical therapy with voriconazole and epigallocatechin gallate.
Ruban VV; Archana PT; Sundararajan M; Geraldine P; Thomas PA
Mycoses; 2018 Mar; 61(3):159-171. PubMed ID: 29064157
[TBL] [Abstract][Full Text] [Related]
9. Antifungal efficacy of natamycin in experimental fusarium solani keratitis.
Dong XH; Gao WJ; He XP
Int J Ophthalmol; 2012; 5(2):143-6. PubMed ID: 22762038
[TBL] [Abstract][Full Text] [Related]
10. Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosis.
Fiscella RG; Moshifar M; Messick CR; Pendland SL; Chandler JW; Viana M
Cornea; 1997 Jul; 16(4):447-9. PubMed ID: 9220243
[TBL] [Abstract][Full Text] [Related]
11. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
[TBL] [Abstract][Full Text] [Related]
12. Niosomes: Do They Increase the Potency of Topical Natamycin Ketorolac Formula in Treating Aspergillus Keratitis? An Experimental Study.
El-Mofty HM; El-Nabarawi MA; Abd El Rehem RT; Teaima MH; Abary MYS; Salah M; Lotfy NM
J Ocul Pharmacol Ther; 2020 Sep; 36(7):545-554. PubMed ID: 32357092
[No Abstract] [Full Text] [Related]
13. Rabbit Fungal Keratitis Model of Fusarium solani Tested Against Three Commercially Available Antifungal Drugs.
Aung TT; Chor WHJ; Lynn MN; Chan ASY; Tan DTH; Beuerman RW
Eye Contact Lens; 2020 Sep; 46(5):274-280. PubMed ID: 32134799
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of topical caspofungin in experimental fusarium keratitis.
Ozturk F; Yavas GF; Kusbeci T; Cetinkaya Z; Inan UU; Ermis SS; Kiraz N
Cornea; 2007 Jul; 26(6):726-8. PubMed ID: 17592325
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antifungal activity of cetrimide (cetyltrimethyl ammonium bromide) against fungal keratitis caused by Fusarium solani.
Mahmoud YA
Mycoses; 2007 Jan; 50(1):64-70. PubMed ID: 17302751
[TBL] [Abstract][Full Text] [Related]
17. Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis.
Gong H; Gong X
Eye Sci; 2013 Jun; 28(2):84-7. PubMed ID: 24396961
[TBL] [Abstract][Full Text] [Related]
18. [Prolonged topical natamycin 5 % therapy before and after keratoplasty for Fusarium keratitis].
Cvetkova N; Köstler J; Prahs P; Helbig H; Dietrich-Ntoukas T
Ophthalmologe; 2016 May; 113(5):420-4. PubMed ID: 26205744
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit.
Nejabat M; Yaqubi N; Khosravi A; Zomorodian K; Ashraf MJ; Salouti R
J Ophthalmol; 2016; 2016():8692830. PubMed ID: 27298734
[TBL] [Abstract][Full Text] [Related]
20. Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates.
Pradhan L; Sharma S; Nalamada S; Sahu SK; Das S; Garg P
Indian J Ophthalmol; 2011; 59(6):512-4. PubMed ID: 22011503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
